1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Olsen, H.B. Ludvigsen, S. Kaarsholm, N.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 284 477 488 10.1006/jmbi.1998.2175 9813131 The relationship between insulin bioactivity and structure in the NH2-terminal A-chain helix. 1998 10.2210/pdb1iog/pdb pdb_00001iog 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2341.619 PROTEIN (INSULIN PRECURSOR) V3G 1 man polymer 3299.706 PROTEIN (INSULIN PRECURSOR) F1E, H10E, Y16E, T27E 1 man polymer no no GIGEQCCTSICSLYQLENYCN GIGEQCCTSICSLYQLENYCN A polypeptide(L) no no EVNQHLCGSELVEALELVCGERGFFYEPK EVNQHLCGSELVEALELVCGERGFFYEPK B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo baker's yeast Saccharomyces sample 9606 PANCREAS Homo sapiens 4932 Saccharomyces cerevisiae human Homo baker's yeast Saccharomyces sample 9606 PANCREAS Homo sapiens 4932 Saccharomyces cerevisiae pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type database_2 struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Derived calculations Database references 1 0 1999-01-13 1 1 2008-04-27 1 2 2011-07-13 1 3 2017-11-29 1 4 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details BNL Y RCSB 1998-08-13 REL REL 100 19 NOESY COSY TOCSY 6.5 307 K distance geometry 15 BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 600 Bruker AMX600 GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A GLY 3 n 3 GLY 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A GLU 1 n 1 GLU 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B GLU 10 n 10 GLU 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B GLU 16 n 16 GLU 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B GLU 27 n 27 GLU 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A CYS 6 -68.98 84.38 1 A SER 9 -178.26 -134.09 1 A CYS 11 57.97 127.62 1 A CYS 20 -45.39 164.58 1 B VAL 2 -108.39 77.03 1 B GLN 4 -85.67 44.89 1 B HIS 5 -72.14 -168.47 1 B SER 9 -156.80 20.86 1 B VAL 18 -51.80 -73.63 1 B TYR 26 -68.19 86.25 2 A ILE 2 -142.56 11.02 2 A CYS 6 -47.79 101.61 2 A CYS 7 -148.86 56.80 2 A THR 8 -162.33 23.18 2 A SER 9 163.48 -115.70 2 B ASN 3 70.78 33.46 2 B GLN 4 66.58 -173.47 2 B SER 9 163.38 36.53 2 B VAL 18 -47.83 -76.50 2 B GLU 21 -58.68 -76.57 2 B PRO 28 -58.27 88.39 3 A SER 9 -152.53 -143.36 3 A CYS 20 -46.91 161.03 3 B VAL 2 72.27 -147.73 3 B ASN 3 -55.25 91.71 3 B SER 9 43.21 28.17 3 B VAL 18 -56.40 -70.96 4 A ILE 2 165.11 -21.21 4 A CYS 6 -62.66 85.95 4 A ILE 10 -103.06 63.44 4 A CYS 11 -41.89 103.11 4 A SER 12 -58.27 -167.28 4 A TYR 14 -39.71 -36.56 4 B VAL 2 -147.04 22.60 4 B SER 9 -153.87 45.74 4 B VAL 18 -49.44 -76.13 4 B GLU 21 -59.32 -72.79 4 B GLU 27 179.85 77.23 5 A ILE 2 68.89 175.96 5 A CYS 7 -104.48 -168.26 5 A THR 8 44.25 27.01 5 A SER 9 165.91 -166.19 5 A CYS 20 -42.94 164.61 5 B ASN 3 176.20 115.90 5 B LEU 6 -117.91 69.70 5 B SER 9 42.86 29.46 5 B VAL 18 -47.78 -70.32 5 B TYR 26 -61.40 94.18 5 B PRO 28 -56.08 101.10 6 A CYS 6 -49.08 93.43 6 A SER 9 163.73 174.41 6 A SER 12 -44.89 153.03 6 A TYR 14 -39.50 -37.05 6 A CYS 20 -45.56 165.36 6 B VAL 2 57.90 95.09 6 B ASN 3 -132.66 -159.58 6 B GLN 4 -49.19 104.78 6 B VAL 18 -51.24 -78.93 6 B GLU 21 -60.06 -76.66 6 B TYR 26 -32.77 112.46 6 B GLU 27 -179.54 79.67 7 A CYS 6 -59.33 93.62 7 A THR 8 86.30 -77.88 7 A SER 9 -76.56 -117.46 7 A CYS 20 -54.80 -165.98 7 B HIS 5 49.58 177.70 7 B SER 9 -158.63 24.38 7 B GLU 27 -162.38 78.28 8 A ILE 2 -153.88 35.88 8 A GLU 4 -161.60 23.25 8 A CYS 7 -151.93 -36.72 8 A SER 9 176.96 -144.94 8 B ASN 3 51.56 -169.25 8 B GLN 4 -162.01 37.70 8 B SER 9 -174.45 37.93 8 B VAL 18 -44.15 -70.01 8 B GLU 21 -59.26 -76.64 8 B TYR 26 -32.93 91.71 9 A CYS 6 -55.95 89.18 9 A CYS 7 -132.36 -37.13 9 A THR 8 -90.05 34.93 9 A SER 9 175.62 -165.03 9 B SER 9 77.20 44.05 9 B VAL 18 -44.09 -76.40 9 B GLU 21 -174.54 -67.41 9 B PHE 25 -105.89 64.27 9 B TYR 26 -59.32 92.20 10 A ILE 2 43.80 -170.99 10 A CYS 6 -56.93 99.68 10 A SER 9 -178.60 -155.91 10 A ILE 10 -153.08 61.34 10 A CYS 11 -37.29 115.84 10 B VAL 2 62.14 -96.33 10 B ASN 3 -50.61 -99.93 10 B GLN 4 69.39 -150.53 10 B SER 9 178.25 35.47 10 B VAL 18 -48.09 -75.81 10 B PHE 25 -104.37 63.00 10 B TYR 26 -58.91 105.62 10 B GLU 27 -154.03 68.60 11 A CYS 6 -66.14 86.37 11 A THR 8 -105.84 41.11 11 A SER 9 161.41 -121.51 11 A ILE 10 -162.47 68.37 11 A CYS 11 -40.74 97.17 11 A SER 12 -46.91 150.36 11 B GLN 4 -148.69 -75.81 11 B HIS 5 -178.72 -176.46 11 B VAL 18 -49.82 -78.84 11 B PHE 25 -102.73 56.80 11 B GLU 27 180.00 77.75 12 A CYS 6 -66.74 86.34 12 A SER 9 -179.86 -172.11 12 B HIS 5 -61.37 -172.21 12 B SER 9 73.22 41.67 12 B VAL 18 -51.32 -80.99 12 B GLU 21 -58.99 -77.46 12 B GLU 27 179.77 75.94 13 A ILE 2 -167.10 -60.74 13 A SER 9 179.24 -171.51 13 A SER 12 -50.18 178.08 13 A CYS 20 -47.02 165.68 13 B VAL 2 78.69 175.09 13 B HIS 5 -179.33 -39.34 13 B SER 9 -176.71 30.52 13 B GLU 21 -59.66 -76.51 13 B TYR 26 64.25 77.79 13 B PRO 28 -57.44 -162.10 14 A CYS 6 -64.17 87.87 14 A THR 8 -89.18 34.15 14 A SER 9 -179.70 -145.89 14 A CYS 11 -42.57 108.88 14 A CYS 20 -44.63 164.79 14 B ASN 3 54.77 -158.48 14 B CYS 7 -142.81 27.22 14 B VAL 18 -53.61 -78.92 14 B PHE 25 -106.62 66.05 14 B GLU 27 -175.55 79.96 15 A CYS 6 -62.59 96.07 15 A SER 9 163.94 171.61 15 A CYS 20 -44.36 163.97 15 B VAL 2 -176.58 126.74 15 B GLN 4 -46.30 158.64 15 B HIS 5 -112.93 -169.61 15 B VAL 18 -56.45 -83.19 15 B GLU 21 -60.55 -76.86 15 B GLU 27 -157.79 85.84 15 B PRO 28 -59.30 97.06 16 A CYS 6 -58.34 88.54 16 A SER 9 174.34 164.62 16 A CYS 20 -47.04 166.07 16 B VAL 18 -45.53 -74.54 16 B GLU 21 -59.71 -72.66 16 B TYR 26 -32.38 115.28 16 B GLU 27 -179.68 73.96 17 A SER 9 167.18 170.79 17 A CYS 20 -48.06 163.06 17 B ASN 3 -141.52 -101.40 17 B VAL 18 -48.96 -81.95 17 B GLU 21 -125.43 -68.38 17 B PHE 25 -106.37 64.31 18 A ILE 2 -80.82 -109.40 18 A CYS 6 -68.59 97.93 18 A CYS 7 -135.87 -41.06 18 A SER 9 -164.50 -118.26 18 A CYS 20 -49.99 165.79 18 B LEU 6 -118.11 79.08 18 B VAL 18 -43.16 -71.85 18 B PHE 25 -106.17 60.02 18 B GLU 27 -179.61 80.26 18 B PRO 28 -59.74 95.96 19 A ILE 2 -59.23 -164.94 19 A GLU 4 -154.29 19.72 19 A CYS 6 -49.90 87.29 19 A SER 9 -171.93 -171.77 19 A SER 12 -43.15 167.10 19 A CYS 20 -41.90 163.35 19 B GLN 4 -170.78 138.46 19 B HIS 5 -173.40 -32.20 19 B LEU 6 -105.52 60.53 19 B SER 9 173.21 35.93 19 B VAL 18 -51.18 -76.08 19 B GLU 21 -58.61 -76.69 19 B GLU 27 -152.83 80.67 INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES 1 N N 2 N N A SER 12 A SER 12 HELX_P A TYR 19 A TYR 19 1 HE2 8 B SER 9 B SER 9 HELX_P B CYS 19 B CYS 19 1 HE3 11 disulf 2.021 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.022 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.022 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE/GROWTH FACTOR HORMONE, HUMAN INSULIN MUTANT, MONOMER, NEUTRAL PH, HORMONE-GROWTH FACTOR COMPLEX INS_HUMAN UNP 1 90 P01308 INS_HUMAN UNP 2 26 P01308 90 110 1IOG 1 21 P01308 A 1 1 21 26 53 1IOG 1 29 P01308 B 2 1 29 2 PHE engineered mutation GLU 1 1IOG B P01308 UNP 25 1 2 HIS engineered mutation GLU 10 1IOG B P01308 UNP 34 10 2 TYR engineered mutation GLU 16 1IOG B P01308 UNP 40 16 2 THR engineered mutation GLU 27 1IOG B P01308 UNP 51 27 1 VAL engineered mutation GLY 3 1IOG A P01308 UNP 92 3 1 P 1